FDA releases annual update on medical countermeasures initiative
The Food and Drug Administration last week reported on its fiscal year 2022 activities to support medical countermeasures, as required by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013. The report reviews the agency’s activities to protect the nation from chemical, biological, radiological, nuclear and emerging infectious disease threats.
Related News Articles
Headline
The Administration for Strategic Preparedness and Response is seeking public feedback on its Hospital Preparedness Program funding formula. The HPP is the…
Headline
Reports of cases of pertussis, also known as whooping cough, are currently five times higher compared to last year, according to the Centers for Disease…
Headline
The Centers for Disease Control and Prevention Oct. 25 announced additional reported cases of E. coli from individuals who ate at McDonald's prior to falling…
Headline
The Department of Health and Human Services Oct. 7 released a fact sheet on actions it is taking to help address the outbreak of Marburg virus in Rwanda. As of…
Headline
AHA President and CEO Rick Pollack Oct. 7 sent a letter to President Biden urging the Administration to take immediate actions to increase the supply of IV…
News
The increasing number of public health emergencies in the U.S., including mass violence incidents and natural disasters, highlight the need for enhanced…